Metropolis Healthcare shares gain 9% over issue price on debut

On a price-to-earnings (P/E) valuation basis, analysts said Metropolis is cheaper than Dr Lal Pathlabs

Shares of Metropolis Healthcare, a diagnostics company, settled nine per cent higher compared to the issue price during stock market debut on Monday. The stock ended at Rs 955 compared to the issue price of Rs 880 per share on the NSE. The scrip touched a high of Rs 982.7 and a low of Rs 935 with nearly Rs 700 crore worth of shares being traded.

Metropolis Healthcare’s Rs 1,200-crore initial public offer (IPO) had garnered nearly six times subscription led by demand from institutional investors. The retail and high net worth individual (HNI) portion of the IPO had seen